Dawn M Bravata1,2,3,4,5, Laura J Myers1,2,3, Greg Arling1,6, Edward J Miech1,2,5,7, Teresa Damush1,2,3,5, Jason J Sico8,9,10, Michael S Phipps11, Alan J Zillich12, Zhangsheng Yu13, Mathew Reeves1,14, Linda S Williams1,2,4,5, Jason Johanning15,16, Seemant Chaturvedi17,18, Fitsum Baye13, Susan Ofner13, Curt Austin2,3, Jared Ferguson2,9, Glenn D Graham1,19,20, Rachel Rhude21, Chad S Kessler22,23, Donald S Higgins19,24, Eric Cheng1,25,26. 1. Department of Veterans Affairs (VA) Health Services Research and Development (HSR&D) Stroke Quality Enhancement Research Initiative, Washington, DC. 2. VA HSR&D Center for Health Information and Communication, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana. 3. Department of Internal Medicine, Indiana University School of Medicine, Indianapolis. 4. Department of Neurology, Indiana University School of Medicine, Indianapolis. 5. Regenstrief Institute, Indianapolis, Indiana. 6. Purdue University School of Nursing, West Lafayette, Indiana. 7. Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis. 8. Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven, Connecticut. 9. Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut. 10. Department of Neurology, Yale University School of Medicine, New Haven, Connecticut. 11. Department of Neurology, University of Maryland School of Medicine, Baltimore. 12. Department of Pharmacy Practice, Purdue University College of Pharmacy, West Lafayette, Indiana. 13. Department of Biostatistics, Indiana University School of Medicine, Indiana University-Purdue University, Indianapolis. 14. Department of Epidemiology, Michigan State University, East Lansing. 15. VA Nebraska-Western Iowa Health Care System-Omaha Division, Omaha. 16. Department of Surgery, University of Nebraska, Omaha. 17. Department of Neurology, Miami VA Medical Center, Miami, Florida. 18. Department of Neurology, University of Miami School of Medicine, Miami, Florida. 19. Specialty Care Services, Department of Veterans Affairs, Washington, DC. 20. Department of Neurology, University of California, San Francisco (UCSF) School of Medicine, San Francisco. 21. VA Inpatient Evaluation Center, Cincinnati, Ohio. 22. Specialty Care Services, VA Central Office, Washington, DC. 23. Department of Emergency Medicine, Durham VA Medical Center, Durham, North Carolina. 24. Department of Neurology, Stratton VA Medical Center, Albany, New York. 25. Department of Neurology, VA Greater Los Angeles Healthcare System, Los Angeles, California. 26. Department of Neurology, David Geffen School of Medicine, UCLA (University of California, Los Angeles).
Abstract
Importance: The timely delivery of guideline-concordant care may reduce the risk of recurrent vascular events for patients with transient ischemic attack (TIA) and minor stroke. Although many health care organizations measure stroke care quality, few evaluate performance for patients with TIA or minor stroke, and most include only a limited subset of guideline-recommended processes. Objective: To assess the quality of guideline-recommended TIA and minor stroke care across the Veterans Health Administration (VHA) system nationwide. Design, Setting, and Participants: This cohort study included 8201 patients with TIA or minor stroke cared for in any VHA emergency department (ED) or inpatient setting during federal fiscal year 2014 (October 1, 2013, through September 31, 2014). Patients with length of stay longer than 6 days, ventilator use, feeding tube use, coma, intensive care unit stay, inpatient rehabilitation stay before discharge, or receipt of thrombolysis were excluded. Outlier facilities for each process of care were identified by constructing 95% CIs around the facility pass rate and national pass rate sites when the 95% CIs did not overlap. Data analysis occurred from January 16, 2016, through June 30, 2017. Main Outcomes and Measures: Ten elements of care were assessed using validated electronic quality measures. Results: In the 8201 patients included in the study (mean [SD] age, 68.8 [11.4] years; 7877 [96.0%] male; 4856 [59.2%] white), performance varied across elements of care: brain imaging by day 2 (6720/7563 [88.9%]; 95% CI, 88.2%-89.6%), antithrombotic use by day 2 (6265/7477 [83.8%]; 95% CI, 83.0%-84.6%), hemoglobin A1c measurement by discharge or within the preceding 120 days (2859/3464 [82.5%]; 95% CI, 81.2%-83.8%), anticoagulation for atrial fibrillation by day 7 after discharge (1003/1222 [82.1%]; 95% CI, 80.0%-84.2%), deep vein thrombosis prophylaxis by day 2 (3253/4346 [74.9%]; 95% CI, 73.6%-76.2%), hypertension control by day 90 after discharge (4292/5979 [71.8%]; 95% CI, 70.7%-72.9%), neurology consultation by day 1 (5521/7823 [70.6%]; 95% CI, 69.6%-71.6%), electrocardiography by day 2 or within 1 day prior (5073/7570 [67.0%]; 95% CI, 65.9%-68.1%), carotid artery imaging by day 2 or within 6 months prior (4923/7685 [64.1%]; 95% CI, 63.0%-65.2%), and moderate- to high-potency statin prescription by day 7 after discharge (3329/7054 [47.2%]; 95% CI, 46.0%-48.4%). Performance varied substantially across facilities (eg, neurology consultation had a facility outlier rate of 53.0%). Performance was higher for admitted patients than for patients cared for only in EDs with the greatest disparity for carotid artery imaging (4478/5927 [75.6%] vs 445/1758 [25.3%]; P < .001). Conclusions and Relevance: This national study of VHA system quality of care for patients with TIA or minor stroke identified opportunities to improve care quality, particularly for patients who were discharged from the ED. Health care systems should engage in ongoing TIA care performance assessment to complement existing stroke performance measurement.
Importance: The timely delivery of guideline-concordant care may reduce the risk of recurrent vascular events for patients with transient ischemic attack (TIA) and minor stroke. Although many health care organizations measure stroke care quality, few evaluate performance for patients with TIA or minor stroke, and most include only a limited subset of guideline-recommended processes. Objective: To assess the quality of guideline-recommended TIA and minor stroke care across the Veterans Health Administration (VHA) system nationwide. Design, Setting, and Participants: This cohort study included 8201 patients with TIA or minor stroke cared for in any VHA emergency department (ED) or inpatient setting during federal fiscal year 2014 (October 1, 2013, through September 31, 2014). Patients with length of stay longer than 6 days, ventilator use, feeding tube use, coma, intensive care unit stay, inpatient rehabilitation stay before discharge, or receipt of thrombolysis were excluded. Outlier facilities for each process of care were identified by constructing 95% CIs around the facility pass rate and national pass rate sites when the 95% CIs did not overlap. Data analysis occurred from January 16, 2016, through June 30, 2017. Main Outcomes and Measures: Ten elements of care were assessed using validated electronic quality measures. Results: In the 8201 patients included in the study (mean [SD] age, 68.8 [11.4] years; 7877 [96.0%] male; 4856 [59.2%] white), performance varied across elements of care: brain imaging by day 2 (6720/7563 [88.9%]; 95% CI, 88.2%-89.6%), antithrombotic use by day 2 (6265/7477 [83.8%]; 95% CI, 83.0%-84.6%), hemoglobin A1c measurement by discharge or within the preceding 120 days (2859/3464 [82.5%]; 95% CI, 81.2%-83.8%), anticoagulation for atrial fibrillation by day 7 after discharge (1003/1222 [82.1%]; 95% CI, 80.0%-84.2%), deep vein thrombosis prophylaxis by day 2 (3253/4346 [74.9%]; 95% CI, 73.6%-76.2%), hypertension control by day 90 after discharge (4292/5979 [71.8%]; 95% CI, 70.7%-72.9%), neurology consultation by day 1 (5521/7823 [70.6%]; 95% CI, 69.6%-71.6%), electrocardiography by day 2 or within 1 day prior (5073/7570 [67.0%]; 95% CI, 65.9%-68.1%), carotid artery imaging by day 2 or within 6 months prior (4923/7685 [64.1%]; 95% CI, 63.0%-65.2%), and moderate- to high-potency statin prescription by day 7 after discharge (3329/7054 [47.2%]; 95% CI, 46.0%-48.4%). Performance varied substantially across facilities (eg, neurology consultation had a facility outlier rate of 53.0%). Performance was higher for admitted patients than for patients cared for only in EDs with the greatest disparity for carotid artery imaging (4478/5927 [75.6%] vs 445/1758 [25.3%]; P < .001). Conclusions and Relevance: This national study of VHA system quality of care for patients with TIA or minor stroke identified opportunities to improve care quality, particularly for patients who were discharged from the ED. Health care systems should engage in ongoing TIA care performance assessment to complement existing stroke performance measurement.
Authors: W N Kernan; C M Viscoli; L M Brass; R W Makuch; P M Sarrel; R S Roberts; M Gent; P Rothwell; R L Sacco; R C Liu; B Boden-Albala; R I Horwitz Journal: Stroke Date: 2000-02 Impact factor: 7.914
Authors: Dawn M Bravata; Laura J Myers; Eric Cheng; Mathew Reeves; Fitsum Baye; Zhangsheng Yu; Teresa Damush; Edward J Miech; Jason Sico; Michael Phipps; Alan Zillich; Jason Johanning; Seemant Chaturvedi; Curt Austin; Jared Ferguson; Bailey Maryfield; Kathy Snow; Susan Ofner; Glenn Graham; Rachel Rhude; Linda S Williams; Greg Arling Journal: Circ Cardiovasc Qual Outcomes Date: 2017-09
Authors: Joseph S Ross; Greg Arling; Susan Ofner; Christianne L Roumie; Salomeh Keyhani; Linda S Williams; Diana L Ordin; Dawn M Bravata Journal: Stroke Date: 2011-06-30 Impact factor: 7.914
Authors: Annemarei Ranta; Susan Dovey; Mark Weatherall; Des O'Dea; John Gommans; Murray Tilyard Journal: Neurology Date: 2015-03-20 Impact factor: 9.910
Authors: Saqib A Chaudhry; Nauman Tariq; Shahram Majidi; Mohammad R Afzal; Ameer E Hassan; Masaki Watanabe; Gustavo J Rodriguez; M Fareed K Suri; Syed Hussain; Adnan I Qureshi Journal: Am J Emerg Med Date: 2013-02-04 Impact factor: 2.469
Authors: Moira K Kapral; Andreas Laupacis; Stephen J Phillips; Frank L Silver; Michael D Hill; Jiming Fang; Janice Richards; Jack V Tu Journal: Stroke Date: 2004-05-13 Impact factor: 7.914
Authors: Barbara J Homoya; Teresa M Damush; Jason J Sico; Edward J Miech; Gregory W Arling; Laura J Myers; Jared B Ferguson; Michael S Phipps; Eric M Cheng; Dawn M Bravata Journal: J Gen Intern Med Date: 2018-11-27 Impact factor: 5.128
Authors: Shelagh B Coutts; Francois Moreau; Negar Asdaghi; Jean-Martin Boulanger; Marie-Christine Camden; Bruce C V Campbell; Andrew M Demchuk; Thalia S Field; Mayank Goyal; Martin Krause; Jennifer Mandzia; Bijoy K Menon; Robert Mikulik; Andrew M Penn; Richard H Swartz; Michael D Hill Journal: JAMA Neurol Date: 2019-12-01 Impact factor: 18.302
Authors: Jennifer A Lewis; Lauren R Samuels; Jason Denton; Gretchen C Edwards; Michael E Matheny; Amelia Maiga; Christopher G Slatore; Eric Grogan; Jane Kim; Robert H Sherrier; Robert S Dittus; Pierre P Massion; Laura Keohane; Sayeh Nikpay; Christianne L Roumie Journal: JNCI Cancer Spectr Date: 2020-06-13
Authors: Teresa M Damush; Lauren S Penney; Edward J Miech; Nicholas A Rattray; Sean A Baird; Ariel J Cheatham; Charles Austin; Ali Sexson; Laura J Myers; Dawn M Bravata Journal: BMC Health Serv Res Date: 2021-05-12 Impact factor: 2.655
Authors: Deborah A Levine; Anthony J Perkins; Jason J Sico; Laura J Myers; Michael S Phipps; Ying Zhang; Dawn M Bravata Journal: Stroke Date: 2021-05-27 Impact factor: 10.170
Authors: Nicolas Raposo; Jean François Albucher; Vanessa Rousseau; Blandine Acket; François Chollet; Jean Marc Olivot Journal: Front Neurol Date: 2018-10-26 Impact factor: 4.003
Authors: Dawn M Bravata; Laura J Myers; Mathew Reeves; Eric M Cheng; Fitsum Baye; Susan Ofner; Edward J Miech; Teresa Damush; Jason J Sico; Alan Zillich; Michael Phipps; Linda S Williams; Seemant Chaturvedi; Jason Johanning; Zhangsheng Yu; Anthony J Perkins; Ying Zhang; Greg Arling Journal: JAMA Netw Open Date: 2019-07-03
Authors: D M Bravata; L J Myers; B Homoya; E J Miech; N A Rattray; A J Perkins; Y Zhang; J Ferguson; J Myers; A J Cheatham; L Murphy; B Giacherio; M Kumar; E Cheng; D A Levine; J J Sico; M J Ward; T M Damush Journal: BMC Neurol Date: 2019-11-20 Impact factor: 2.474